FRONTIERS
Molecular Biotechnology
Synthetic Biology
Bioprocess Engineering
Bioinformatics
VOLUME 1 · 2026
Authors should read the aims and scope before preparing a submission. A manuscript must be original, approved by all authors and not under consideration by another journal.
Submit a separate title page and anonymized manuscript. The title page should include author names, affiliations, corresponding-author details, ORCID iDs where available, funding, competing interests and author contributions. Remove identifying details from the review file and its document properties.
Describe organisms, strains, cell lines, sampling, controls, replication, randomization, blinding, reagents, equipment, software and statistical methods in enough detail for assessment. Report ethical approval, permits, biosafety measures and accession numbers where relevant.
Include a Data Availability Statement. Deposit sequence, structure, expression and other community-standard data in an appropriate repository and cite the accession. Explain how code, protocols, specimens, strains or other materials may be obtained, including lawful or ethical restrictions.
Authorship is limited to people who made a substantial contribution, approved the submitted version and accept responsibility for the work. AI tools cannot be authors. Material use of generative AI in writing, coding, analysis or image preparation must be disclosed.
Online submissions are temporarily closed while BF completes its editorial setup. This page will be updated when submissions open.
Molecular Biotechnology
Synthetic Biology
Bioprocess Engineering
Bioinformatics
VOLUME 1 · 2026